OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $85,000 Invested

2007

Massachusetts General Hospital (P)

Tara Spires-Jones, DPhil

Sirtuins as modifiers of neurodegeneration in a mouse model of frontotemporal dementia

  • Funding Amount: $85,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed